Zdrowie i gospodarka · 21/03/2024

FDA Revokes Six COVID-19 Emergency Use Authorizations for In Vitro Diagnostic Devices

The US Food and Drug Administration (FDA) has revoked six Emergency Use Authorizations (EUAs) for COVID-19 diagnostic devices, including kits from Life Technologies Corp., Bio-Rad Laboratories, Inc., Revvity, Inc., bioMerieux SA, and Luminex Corp., due to changes in the pandemic situation.